MARKET

CDMOP

Avid Bioservices
CDMOP
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-93.1606
18.05
17.86
41,293,195.15
Avid Bioservices Inc reports results for the quarter ended in January - Earnings Summary
Avid Bioservices Inc reports results for the quarter ended in January. The company reported a quarterly adjusted loss of 9 cents per share. Revenue fell 11.1% to $33.82 million from a year ago. The average analyst rating on the company's shares is "buy"
Reuters · 1d ago
AVID BIOSERVICES OUTLOOK FY REVENUE USD 137-147 MILLION
Reuters · 1d ago
AVID BIOSERVICES INC - QTRLY SHR LOSS $ 0.09
Reuters · 1d ago
AVID BIOSERVICES REPORTS FINANCIAL RESULTS FOR THIRD QUARTER ENDED JANUARY 31, 2024
Reuters · 1d ago
UPDATE 1-EnQuest selling stake in North Sea Golden Eagle oilfield, sources say
EnQuest selling stake in North Sea Golden Eagle oilfield, sources say. Britain's EnQuest is looking to sell its 27% stake in the Golden Eagle field in the British North Sea. The company bought the stake from Suncor in 2021 for $325 million. EnQuest has struggled in recent years with high debt levels.
Reuters · 04/16 14:42
Avid Bioservices Inc <CDMO.OQ> expected to post a loss of 5 cents a share - Earnings Preview
Avid Bioservices Inc expected to post a loss of 5 cents a share. The company is expected to report a 12.0% decrease in quarterly revenue to $33.452 million from $38.02 million.
Reuters · 03/29 21:14
Avid Bioservices Inc <CDMO.OQ> expected to post a loss of 5 cents a share - Earnings Preview
Avid Bioservices Inc expected to post a loss of 5 cents a share - Earnings Preview. The company is expected to report a 12.0% decrease in quarterly revenue to $33.452 million.
Reuters · 03/15 21:24
Avid Bioservices Inc <CDMO.OQ> expected to post a loss of 6 cents a share - Earnings Preview
Avid Bioservices Inc expected to post a loss of 6 cents a share - Earnings Preview. The company is expected to report a fall in quarterly revenue to $33.594 million from $38.02 million.
Reuters · 03/08 11:11
More

Webull offers Avid Bioservices stock information, including NASDAQ: CDMOP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CDMOP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CDMOP stock methods without spending real money on the virtual paper trading platform.